The global Neuroscience Antibodies and Assays market was valued at US$ 2415.4 million in 2023 and is anticipated to reach US$ 3691.5 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.

Neuroscience Antibodies and Assays Market

The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.

North American market for Neuroscience Antibodies and Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Neuroscience Antibodies and Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Neuroscience Antibodies and Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Neuroscience Antibodies and Assays include Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend and Santa Cruz Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Neuroscience Antibodies and Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroscience Antibodies and Assays.

Report Scope

The Neuroscience Antibodies and Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuroscience Antibodies and Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neuroscience Antibodies and Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Neuroscience Antibodies and Assays Market Report

Report Metric	Details
Report Name	Neuroscience Antibodies and Assays Market
Accounted market size in 2023	US$ 2415.4 million
Forecasted market size in 2030	US$ 3691.5 million
CAGR	5.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Consumables Instruments
Segment by Application	Pharmaceutical & Biotechnology Companies Academic & Research Institutes Hospitals & Diagnostic Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend, Santa Cruz Biotechnology, Roche, Siemens
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroscience Antibodies and Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Neuroscience Antibodies and Assays Market growing?

Ans: The Neuroscience Antibodies and Assays Market witnessing a CAGR of 5.8% during the forecast period 2024-2030.

What is the Neuroscience Antibodies and Assays Market size in 2030?

Ans: The Neuroscience Antibodies and Assays Market size in 2030 will be US$ 3691.5 million.

Who are the main players in the Neuroscience Antibodies and Assays Market report?

Ans: The main players in the Neuroscience Antibodies and Assays Market are Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend, Santa Cruz Biotechnology, Roche, Siemens

What are the Application segmentation covered in the Neuroscience Antibodies and Assays Market report?

Ans: The Applications covered in the Neuroscience Antibodies and Assays Market report are Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers

What are the Type segmentation covered in the Neuroscience Antibodies and Assays Market report?

Ans: The Types covered in the Neuroscience Antibodies and Assays Market report are Consumables, Instruments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Consumables

1.2.3 Instruments

1.3 Market by Application

1.3.1 Global Neuroscience Antibodies and Assays Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical & Biotechnology Companies

1.3.3 Academic & Research Institutes

1.3.4 Hospitals & Diagnostic Centers

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neuroscience Antibodies and Assays Market Perspective (2019-2030)

2.2 Neuroscience Antibodies and Assays Growth Trends by Region

2.2.1 Global Neuroscience Antibodies and Assays Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Neuroscience Antibodies and Assays Historic Market Size by Region (2019-2024)

2.2.3 Neuroscience Antibodies and Assays Forecasted Market Size by Region (2025-2030)

2.3 Neuroscience Antibodies and Assays Market Dynamics

2.3.1 Neuroscience Antibodies and Assays Industry Trends

2.3.2 Neuroscience Antibodies and Assays Market Drivers

2.3.3 Neuroscience Antibodies and Assays Market Challenges

2.3.4 Neuroscience Antibodies and Assays Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Neuroscience Antibodies and Assays Players by Revenue

3.1.1 Global Top Neuroscience Antibodies and Assays Players by Revenue (2019-2024)

3.1.2 Global Neuroscience Antibodies and Assays Revenue Market Share by Players (2019-2024)

3.2 Global Neuroscience Antibodies and Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Neuroscience Antibodies and Assays Revenue

3.4 Global Neuroscience Antibodies and Assays Market Concentration Ratio

3.4.1 Global Neuroscience Antibodies and Assays Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Revenue in 2023

3.5 Neuroscience Antibodies and Assays Key Players Head office and Area Served

3.6 Key Players Neuroscience Antibodies and Assays Product Solution and Service

3.7 Date of Enter into Neuroscience Antibodies and Assays Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Neuroscience Antibodies and Assays Breakdown Data by Type

4.1 Global Neuroscience Antibodies and Assays Historic Market Size by Type (2019-2024)

4.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2025-2030)

5 Neuroscience Antibodies and Assays Breakdown Data by Application

5.1 Global Neuroscience Antibodies and Assays Historic Market Size by Application (2019-2024)

5.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Neuroscience Antibodies and Assays Market Size (2019-2030)

6.2 North America Neuroscience Antibodies and Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Neuroscience Antibodies and Assays Market Size by Country (2019-2024)

6.4 North America Neuroscience Antibodies and Assays Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Neuroscience Antibodies and Assays Market Size (2019-2030)

7.2 Europe Neuroscience Antibodies and Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Neuroscience Antibodies and Assays Market Size by Country (2019-2024)

7.4 Europe Neuroscience Antibodies and Assays Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size (2019-2030)

8.2 Asia-Pacific Neuroscience Antibodies and Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2019-2024)

8.4 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Neuroscience Antibodies and Assays Market Size (2019-2030)

9.2 Latin America Neuroscience Antibodies and Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Neuroscience Antibodies and Assays Market Size by Country (2019-2024)

9.4 Latin America Neuroscience Antibodies and Assays Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size (2019-2030)

10.2 Middle East & Africa Neuroscience Antibodies and Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2019-2024)

10.4 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher

11.1.1 Thermo Fisher Company Detail

11.1.2 Thermo Fisher Business Overview

11.1.3 Thermo Fisher Neuroscience Antibodies and Assays Introduction

11.1.4 Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2019-2024)

11.1.5 Thermo Fisher Recent Development

11.2 Abcam

11.2.1 Abcam Company Detail

11.2.2 Abcam Business Overview

11.2.3 Abcam Neuroscience Antibodies and Assays Introduction

11.2.4 Abcam Revenue in Neuroscience Antibodies and Assays Business (2019-2024)

11.2.5 Abcam Recent Development

11.3 Bio-Rad

11.3.1 Bio-Rad Company Detail

11.3.2 Bio-Rad Business Overview

11.3.3 Bio-Rad Neuroscience Antibodies and Assays Introduction

11.3.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2019-2024)

11.3.5 Bio-Rad Recent Development

11.4 Merck

11.4.1 Merck Company Detail

11.4.2 Merck Business Overview

11.4.3 Merck Neuroscience Antibodies and Assays Introduction

11.4.4 Merck Revenue in Neuroscience Antibodies and Assays Business (2019-2024)

11.4.5 Merck Recent Development

11.5 Cell Signaling Technology

11.5.1 Cell Signaling Technology Company Detail

11.5.2 Cell Signaling Technology Business Overview

11.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Introduction

11.5.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2019-2024)

11.5.5 Cell Signaling Technology Recent Development

11.6 Genscript

11.6.1 Genscript Company Detail

11.6.2 Genscript Business Overview

11.6.3 Genscript Neuroscience Antibodies and Assays Introduction

11.6.4 Genscript Revenue in Neuroscience Antibodies and Assays Business (2019-2024)

11.6.5 Genscript Recent Development

11.7 Rockland Immunochemicals

11.7.1 Rockland Immunochemicals Company Detail

11.7.2 Rockland Immunochemicals Business Overview

11.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Introduction

11.7.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2019-2024)

11.7.5 Rockland Immunochemicals Recent Development

11.8 BioLegend

11.8.1 BioLegend Company Detail

11.8.2 BioLegend Business Overview

11.8.3 BioLegend Neuroscience Antibodies and Assays Introduction

11.8.4 BioLegend Revenue in Neuroscience Antibodies and Assays Business (2019-2024)

11.8.5 BioLegend Recent Development

11.9 Santa Cruz Biotechnology

11.9.1 Santa Cruz Biotechnology Company Detail

11.9.2 Santa Cruz Biotechnology Business Overview

11.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Introduction

11.9.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2019-2024)

11.9.5 Santa Cruz Biotechnology Recent Development

11.10 Roche

11.10.1 Roche Company Detail

11.10.2 Roche Business Overview

11.10.3 Roche Neuroscience Antibodies and Assays Introduction

11.10.4 Roche Revenue in Neuroscience Antibodies and Assays Business (2019-2024)

11.10.5 Roche Recent Development

11.11 Siemens

11.11.1 Siemens Company Detail

11.11.2 Siemens Business Overview

11.11.3 Siemens Neuroscience Antibodies and Assays Introduction

11.11.4 Siemens Revenue in Neuroscience Antibodies and Assays Business (2019-2024)

11.11.5 Siemens Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Cell Signaling Technology

GenScript

Rockland Immunochemicals

BioLegend

Santa Cruz Biotechnology

Roche

Siemens AG

List of Tables

Table 1. Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Consumables

Table 3. Key Players of Instruments

Table 4. Global Neuroscience Antibodies and Assays Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Neuroscience Antibodies and Assays Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Neuroscience Antibodies and Assays Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Neuroscience Antibodies and Assays Market Share by Region (2019-2024)

Table 8. Global Neuroscience Antibodies and Assays Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Neuroscience Antibodies and Assays Market Share by Region (2025-2030)

Table 10. Neuroscience Antibodies and Assays Market Trends

Table 11. Neuroscience Antibodies and Assays Market Drivers

Table 12. Neuroscience Antibodies and Assays Market Challenges

Table 13. Neuroscience Antibodies and Assays Market Restraints

Table 14. Global Neuroscience Antibodies and Assays Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Neuroscience Antibodies and Assays Market Share by Players (2019-2024)

Table 16. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2023)

Table 17. Ranking of Global Top Neuroscience Antibodies and Assays Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Neuroscience Antibodies and Assays Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Neuroscience Antibodies and Assays Product Solution and Service

Table 21. Date of Enter into Neuroscience Antibodies and Assays Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Neuroscience Antibodies and Assays Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2019-2024)

Table 25. Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2025-2030)

Table 27. Global Neuroscience Antibodies and Assays Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2019-2024)

Table 29. Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2025-2030)

Table 31. North America Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Neuroscience Antibodies and Assays Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Neuroscience Antibodies and Assays Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Neuroscience Antibodies and Assays Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Neuroscience Antibodies and Assays Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Neuroscience Antibodies and Assays Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Neuroscience Antibodies and Assays Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Neuroscience Antibodies and Assays Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2025-2030) & (US$ Million)

Table 46. Thermo Fisher Company Detail

Table 47. Thermo Fisher Business Overview

Table 48. Thermo Fisher Neuroscience Antibodies and Assays Product

Table 49. Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2019-2024) & (US$ Million)

Table 50. Thermo Fisher Recent Development

Table 51. Abcam Company Detail

Table 52. Abcam Business Overview

Table 53. Abcam Neuroscience Antibodies and Assays Product

Table 54. Abcam Revenue in Neuroscience Antibodies and Assays Business (2019-2024) & (US$ Million)

Table 55. Abcam Recent Development

Table 56. Bio-Rad Company Detail

Table 57. Bio-Rad Business Overview

Table 58. Bio-Rad Neuroscience Antibodies and Assays Product

Table 59. Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2019-2024) & (US$ Million)

Table 60. Bio-Rad Recent Development

Table 61. Merck Company Detail

Table 62. Merck Business Overview

Table 63. Merck Neuroscience Antibodies and Assays Product

Table 64. Merck Revenue in Neuroscience Antibodies and Assays Business (2019-2024) & (US$ Million)

Table 65. Merck Recent Development

Table 66. Cell Signaling Technology Company Detail

Table 67. Cell Signaling Technology Business Overview

Table 68. Cell Signaling Technology Neuroscience Antibodies and Assays Product

Table 69. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2019-2024) & (US$ Million)

Table 70. Cell Signaling Technology Recent Development

Table 71. Genscript Company Detail

Table 72. Genscript Business Overview

Table 73. Genscript Neuroscience Antibodies and Assays Product

Table 74. Genscript Revenue in Neuroscience Antibodies and Assays Business (2019-2024) & (US$ Million)

Table 75. Genscript Recent Development

Table 76. Rockland Immunochemicals Company Detail

Table 77. Rockland Immunochemicals Business Overview

Table 78. Rockland Immunochemicals Neuroscience Antibodies and Assays Product

Table 79. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2019-2024) & (US$ Million)

Table 80. Rockland Immunochemicals Recent Development

Table 81. BioLegend Company Detail

Table 82. BioLegend Business Overview

Table 83. BioLegend Neuroscience Antibodies and Assays Product

Table 84. BioLegend Revenue in Neuroscience Antibodies and Assays Business (2019-2024) & (US$ Million)

Table 85. BioLegend Recent Development

Table 86. Santa Cruz Biotechnology Company Detail

Table 87. Santa Cruz Biotechnology Business Overview

Table 88. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product

Table 89. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2019-2024) & (US$ Million)

Table 90. Santa Cruz Biotechnology Recent Development

Table 91. Roche Company Detail

Table 92. Roche Business Overview

Table 93. Roche Neuroscience Antibodies and Assays Product

Table 94. Roche Revenue in Neuroscience Antibodies and Assays Business (2019-2024) & (US$ Million)

Table 95. Roche Recent Development

Table 96. Siemens Company Detail

Table 97. Siemens Business Overview

Table 98. Siemens Neuroscience Antibodies and Assays Product

Table 99. Siemens Revenue in Neuroscience Antibodies and Assays Business (2019-2024) & (US$ Million)

Table 100. Siemens Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Neuroscience Antibodies and Assays Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Neuroscience Antibodies and Assays Market Share by Type: 2023 VS 2030

Figure 3. Consumables Features

Figure 4. Instruments Features

Figure 5. Global Neuroscience Antibodies and Assays Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Neuroscience Antibodies and Assays Market Share by Application: 2023 VS 2030

Figure 7. Pharmaceutical & Biotechnology Companies Case Studies

Figure 8. Academic & Research Institutes Case Studies

Figure 9. Hospitals & Diagnostic Centers Case Studies

Figure 10. Neuroscience Antibodies and Assays Report Years Considered

Figure 11. Global Neuroscience Antibodies and Assays Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Neuroscience Antibodies and Assays Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Neuroscience Antibodies and Assays Market Share by Region: 2023 VS 2030

Figure 14. Global Neuroscience Antibodies and Assays Market Share by Players in 2023

Figure 15. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Revenue in 2023

Figure 17. North America Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Neuroscience Antibodies and Assays Market Share by Country (2019-2030)

Figure 19. United States Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Neuroscience Antibodies and Assays Market Share by Country (2019-2030)

Figure 23. Germany Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Neuroscience Antibodies and Assays Market Share by Region (2019-2030)

Figure 31. China Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Neuroscience Antibodies and Assays Market Share by Country (2019-2030)

Figure 39. Mexico Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Neuroscience Antibodies and Assays Market Share by Country (2019-2030)

Figure 43. Turkey Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Neuroscience Antibodies and Assays Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Thermo Fisher Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2019-2024)

Figure 46. Abcam Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2019-2024)

Figure 47. Bio-Rad Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2019-2024)

Figure 48. Merck Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2019-2024)

Figure 49. Cell Signaling Technology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2019-2024)

Figure 50. Genscript Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2019-2024)

Figure 51. Rockland Immunochemicals Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2019-2024)

Figure 52. BioLegend Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2019-2024)

Figure 53. Santa Cruz Biotechnology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2019-2024)

Figure 54. Roche Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2019-2024)

Figure 55. Siemens Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions